Skip to main content
. 2015 Jul 29;56(5):1338–1344. doi: 10.3349/ymj.2015.56.5.1338

Table 4. Univariate and Multivariate Analysis between the FLT Group and the PTC Group According to Nodule Size.

Univariate Multivariate
OR 95% CI p value OR 95% CI p value
Nodule size<10 mm
 TSH>2.50 µIU/mL 3.883 1.692-8.911 0.001
 Tg-Ab positivity 18.99 6.298-51.441 <0.001 4.985 1.201-20.689 0.027
 TPO-Ab positivity 5.447 2.278-13.029 <0.001
 Taller than wider 0.469 0.211-1.043 0.063 0.337 0.091-1.243 0.102
 Absence of calcification 1.750 0.734-4.174 0.207
 Presence of DTD pattern 48.800 15.172-156.958 <0.001 29.265 7.788-109.970 <0.001
Nodule size≥10 mm
 TSH>2.50 µIU/mL 7.000 1.498-32.720 0.013
 Tg-Ab positivity 3.600 0.832-15.572 0.086
 TPO-Ab positivity 2.400 0.567-10.155 0.234
 Taller than wider 1.393 0.290-6.679 0.679
 Absence of calcification 12.857 1.459-113.278 0.021 12.487 1.093-142.673 0.042
 Presence of DTD pattern 17.500 3.171-96.575 0.001 17.079 2.464-118.388 0.004

FLT, focal lymphocytic thyroiditis; PTC, papillary thyroid cancer; TSH, thyrotropin; Tg-Ab, thyroglobulin antibody; TPO-Ab, thyroid peroxidase antibody; DTD pattern, "diffuse thyroid disease" pattern on US; OR, odds ratio; CI, confidence interval; US, ultrasound.